Research is an essential endeavor at the First Faculty of Medicine. Our scientists and researchers conduct basic, translational, epidemiologic and clinical research across a broad spectrum of biomedical topics. In a tight cooperation with the General University Hospital and other partners, we bring research from “bench to bedside”.
Biotechnology and Biomedicine Centre in Vestec (BIOCEV) supported by the European Regional Development Fund. Joint project of the Academy of Sciences and Charles University to establish European centre of excellence in biomedicine and biotechnology. First Fakulty of Medicine participate particularly at the programms Development of Diagnostic and Therapeutic Procedures, Cellular Biology and Virology, Functional Genomics, and Biomaterials and Tissue Engineering. The research projects of the First Medical faculty are carried out in the laboratories of the Department BIOCEV 1. LF UK and BIOCEV laboratories of the Institutes of Anatomy, Microbiology and Immunology, Pathophysiology, and Department of Pediatrics and Adolescent Medicine.
Centre for Advanced Preclinical Imaging (CAPI): a top-notch facility enabling various form of visualization in experimental animals including CT, MRI, PET/SPECT and MPI. The center is integrated in the pan-European research infrastructure EUROBIOIMAGING.
The NationalCentre for Medical Genomics (NCMG) is a distributed scientific infrastructure, which consists of the genomic laboratories of the First Faculty of Medicine, Second Faculty of Medicine and Faculty of Medicine in Pilsen, Charles University in Prague, General University Hospital in Prague, Motol University Hospital; BIOCEV; Department of Internal Medicine, Hematology and Oncology (IHOK) and Centre of molecular biology and gene therapy (CMBGT) at University Hospital Brno; Central European Institute of Technology (CEITEC) at Masaryk University at Brno; Institute of Molecular and Translational Medicine at Faculty of Medicine and Dentistry at Palacký University Olomouc; University Hospital in Pilsen. The objective of NCMG is to provide for an operation of next generation sequencing platforms and subsequent technologies for analysis of human genomes and to allow qualified usage of these technologies in biomedical research and translational medicine in Czech Republic.
